These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8094624)

  • 21. Multidrug resistance: a novel class of membrane-associated transport proteins is identified.
    Gros P; Shustik C
    Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020
    [No Abstract]   [Full Text] [Related]  

  • 22. Multidrug resistance and its circumvention.
    Beck WT
    Eur J Cancer; 1990 Apr; 26(4):513-5. PubMed ID: 1972629
    [No Abstract]   [Full Text] [Related]  

  • 23. Multidrug resistance: clinical findings and implications.
    Friedlander ML; Bell DR
    Cancer Treat Res; 1989; 42():63-77. PubMed ID: 2577108
    [No Abstract]   [Full Text] [Related]  

  • 24. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
    Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
    J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.
    Lum BL; Fisher GA; Brophy NA; Yahanda AM; Adler KM; Kaubisch S; Halsey J; Sikic BI
    Cancer; 1993 Dec; 72(11 Suppl):3502-14. PubMed ID: 7902206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.
    Ling V
    Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of P-glycoprotein in human leukemias using monoclonal antibodies.
    Mattern J; Efferth T; Bak M; Ho AD; Volm M
    Blut; 1989 Apr; 58(4):215-7. PubMed ID: 2565123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the multidrug resistance efflux pump.
    Wigler PW; Patterson FK
    Biochim Biophys Acta; 1993 Oct; 1154(2):173-81. PubMed ID: 8105892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the multidrug transporter a flippase?
    Higgins CF; Gottesman MM
    Trends Biochem Sci; 1992 Jan; 17(1):18-21. PubMed ID: 1374941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance: molecular biology and clinical relevance.
    Rothenberg M; Ling V
    J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
    [No Abstract]   [Full Text] [Related]  

  • 32. Multidrug resistance in human tumors.
    Bellamy WT
    Curr Opin Oncol; 1990 Dec; 2(6):1126-32. PubMed ID: 1983090
    [No Abstract]   [Full Text] [Related]  

  • 33. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
    Dixon AR; Bell J; Ellis IO; Elston CW; Blamey RW
    Br J Cancer; 1992 Sep; 66(3):537-41. PubMed ID: 1355661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug resistance in cancer.
    Kartner N; Ling V
    Sci Am; 1989 Mar; 260(3):44-51. PubMed ID: 2564696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance and P-glycoprotein expression.
    Ling V
    Ann N Y Acad Sci; 1987; 507():7-8. PubMed ID: 2894794
    [No Abstract]   [Full Text] [Related]  

  • 36. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.
    Webster L; Linsenmeyer M; Millward M; Morton C; Bishop J; Woodcock D
    J Natl Cancer Inst; 1993 Oct; 85(20):1685-90. PubMed ID: 8105099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
    Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
    J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P-glycoprotein and multidrug resistance.
    Skubitz KM
    Am J Clin Pathol; 1990 Jan; 93(1):156-7. PubMed ID: 1967202
    [No Abstract]   [Full Text] [Related]  

  • 40. Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs.
    Fairchild CR; Cowan KH
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):361-7. PubMed ID: 1671383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.